Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study

Erstveröffentlichung

2020

Authors

Langer, Thorsten

Clemens, Eva

Broer, Linda

Maier, Lara

Uitterlinden, Andre G.

et al.

Wissenschaftlicher Artikel

Published in

European Journal of Cancer ; 138 (2020). - S. 212-224. - ISSN 0959-8049. - eISSN 1879-0852

Link to publication

https://dx.doi.org/10.1016/j.ejca.2020.07.019

Faculties

Medizinische Fakultät

Institutions

UKU. Institut für Naturheilkunde und Klinische Pharmakologie
Institut für Epidemiologie und Medizinische Biometrie

Subject headings

[Free subject headings]: Cancer survivors | Childhood cancer | Anti-neoplastic drugs | Cisplatin: carboplatin | Drug-induced ototoxicity | Adverse drug reaction | Pharmacogenetics | Genetic markers | Multicenter cohort study | CISPLATIN-INDUCED OTOTOXICITY | INDUCED HEARING-LOSS | VARIANTS | TPMT | CHILDREN | COMT | ACYP2 | SENSITIVITY | PREDICTORS | OCT2
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record